Key Differences Between Archaea and Bacteria

Archaea and bacteria look alike under a microscope and share the basic prokaryotic body plan of a cell without a nucleus, but their biochemistry is so different that they occupy entirely separate branches on the tree of life. Carl Woese’s discovery in the late 1970s that these organisms represent a distinct domain, not just unusual bacteria, upended how biologists classify living things and led to the now-standard three-domain system of Archaea, Bacteria, and Eukarya.¹ The differences between the two run deep, from the chemistry of their cell membranes to the way they copy DNA, power their metabolism, and swim.

Membranes Built from Different Chemistry

The most fundamental structural difference between archaea and bacteria sits in the cell membrane itself. Bacterial membranes are made of fatty acid chains linked to a glycerol backbone by ester bonds. Archaeal membranes use a completely different toolkit: branched chains called isoprenoids attached to a mirror-image glycerol backbone by ether bonds.² That three-part difference (branched versus straight chains, ether versus ester bonds, and opposite-handed glycerol) means the two groups independently evolved entirely different ways of building a cell membrane.

Despite those chemical differences, both membrane types do the same job of keeping the cell’s interior stable across a wide range of environmental conditions.³ The archaeal version, however, comes with built-in advantages for handling temperature swings. Archaeal isoprenoid chains maintain proper membrane fluidity across the full biological temperature range, whereas bacteria must constantly adjust their fatty acid composition to stay within a functional window near their growth temperature.⁴

Some archaea take this a step further by producing tetraether lipids, molecules so long they span the entire membrane and create a single-layer sheet instead of the usual double-layer sandwich. Recent work using neutron diffraction has shown that mixing these membrane-spanning tetraethers with shorter diether lipids actually produces a more stable and orderly membrane under heat stress than tetraethers alone, suggesting archaea fine-tune their membranes with a blend of lipid types.⁵

The Genetic Machinery Looks More Eukaryotic Than Bacterial

If the membrane chemistry makes archaea look alien compared to bacteria, their gene-reading equipment makes them look surprisingly familiar to anyone who studies human cells. The enzyme that copies DNA into RNA, called RNA polymerase, is a case in point. In bacteria, this enzyme is relatively simple. In archaea, the RNA polymerase closely resembles the more complex version found in eukaryotic cells, sharing subunit composition, overall architecture, and structural layout with the eukaryotic RNA polymerase II.⁶ The similarity is so strong that researchers have proposed naming archaeal RNA polymerase subunits using the same system as eukaryotic ones.⁷

The resemblance extends beyond RNA polymerase. The transcription factors that archaea use to start reading a gene, including a protein called TBP that recognizes specific DNA sequences, are simplified versions of the ones eukaryotes use. Bacteria rely on a completely different system involving a protein called sigma factor. This means that on the level of how genes get turned on, archaea and eukaryotes are playing the same game with slightly different pieces, while bacteria are playing a different game entirely.

Histones and DNA Packaging

Most people associate histones, the spool-like proteins that DNA wraps around, with eukaryotic cells. But most archaea also have histones. These archaeal histones help organize and compact the genome, and recent research suggests they assemble into variable-length structures on DNA, sometimes described as “hypernucleosomes,” which can also influence which genes get read.⁸ Bacteria, by contrast, do not have histones. They use a different set of proteins called nucleoid-associated proteins to manage their chromosomes.

Not all archaea follow this pattern. Salt-loving archaea (halophiles) appear to use their histone-like proteins in a different way. In species like Halobacterium salinarum and Haloferax volcanii, histone proteins are nonessential and present at levels too low to package the whole genome. Instead, they bind in discrete spots, more like a gene-regulating protein responding to salt stress than a general DNA organizer.⁹ The diversity of histone use within archaea alone tells us these proteins are more flexible in function than the textbook picture of neatly wound eukaryotic chromosomes might suggest.

Methanogenesis and Other Exclusive Metabolisms

Bacteria are famous metabolic generalists. They photosynthesize, break down organic matter, fix nitrogen, and run dozens of other chemical processes. Archaea can do a lot of metabolic work too, but they hold a monopoly on one process: methanogenesis, the biological production of methane. No bacterium, no eukaryote, and no virus carries it out. It belongs exclusively to archaea.¹⁰ Methanogenic archaea use hydrogen and carbon dioxide, formate, methylated compounds, or acetate as their energy and carbon sources, producing methane as a waste product in a way that is chemically unlike anything else in biology.¹¹

The exclusivity of methanogenesis appears to be a consequence of its complexity. The pathway requires so many specialized genes that horizontal gene transfer, the usual way microbes pick up new metabolic tricks, apparently cannot deliver the whole package at once. There is little evidence that any non-archaeal lineage has ever acquired methanogenesis from an archaeon.¹²

In the global nitrogen cycle, archaea and bacteria both oxidize ammonia, but they partition the work by nutrient level. Ammonia-oxidizing archaea thrive under extremely low ammonium concentrations, with one well-studied marine species sustaining high oxidation rates at ammonium levels typical of open oceans.¹³ Ammonia-oxidizing bacteria, on the other hand, dominate when ammonium is more abundant. Direct competition experiments in freshwater cultures confirmed this split: archaea won at low ammonium, bacteria won at high ammonium.¹⁴ In strongly acidic soils, archaeal ammonia oxidizers appear to dominate nitrification regardless of concentration.¹⁵

Swimming with Different Motors

Both archaea and bacteria swim using rotating filaments, and for a long time people assumed they were essentially the same structure. They are not. Bacterial flagella and archaeal swimming appendages (called archaella) do not share a common ancestor, are built from unrelated proteins, and run on different fuel. Bacterial flagella are powered by the flow of ions across the cell membrane. Archaella are powered by ATP, the same energy currency that drives most cellular work.¹⁶ The archaellum has been called the simplest known molecular propeller.¹⁷

Structurally, the archaellum lacks the central hollow channel that bacterial flagella use to push new protein subunits to the growing tip. Instead, archaellar subunits are added at the base, more like how a related structure in bacteria called a type IV pilus is built. But the archaellum is still structurally distinct from type IV pili too, with extensive contacts between neighboring subunits and no central pore.¹⁸ The convergent evolution here is striking: two entirely unrelated molecular machines arrived at the same basic solution (a spinning helical tail) for the same problem (moving through liquid).

Cell Division Without Consensus

Most bacteria divide using a well-understood system centered on a protein called FtsZ, which forms a ring at the cell’s midpoint and pinches the membrane in two. Some archaea also use FtsZ, but the broader picture is messier. Comparative genomic analysis has revealed at least three distinct membrane-remodeling systems across archaea. Some groups in the Euryarchaeota use FtsZ-based division resembling the bacterial system. Others, like the Sulfolobales and Desulfurococcales, divide using a system related to the ESCRT-III machinery that eukaryotic cells employ to reshape membranes. A third group, the Thermoproteales, appears to use an actin-related protein in a system that may be unique to archaea.¹⁹ No single division mechanism unites all archaea, which is another sign of how internally diverse this domain actually is.

Why No Archaeal Pathogens?

Bacteria include some of humanity’s most dangerous pathogens. Archaea include zero confirmed ones. Despite being abundant in the human gut and on skin, no archaeon has ever been shown to cause disease. Why not? There are at least two competing explanations, and both may be partially correct.

One hypothesis focuses on the viruses that infect each domain. Bacterial virulence factors, the molecular weapons that pathogens use against host cells, are frequently carried on phages (bacterial viruses) or mobile genetic elements. Archaeal viruses are structurally different and cannot infect bacteria, and bacterial phages cannot infect archaea. This means the horizontal transfer of virulence genes between the two domains is essentially blocked by incompatible viral biology.²⁰

A newer hypothesis looks at metabolism and habitat together. Bacterial pathogens overwhelmingly rely on organic compounds for energy and carbon. Among archaea, the species capable of that same metabolic strategy tend to live in extreme environments where multicellular hosts simply do not exist. Meanwhile, the archaea that do live inside animals, like the methane producers in your gut, rely on metabolisms that may be incompatible with the tissue-invading lifestyle a pathogen needs.²¹

The gut archaeon Methanobrevibacter smithii illustrates the cooperative rather than harmful relationship archaea maintain with animal hosts. It is the dominant archaeon in the human intestine, where it consumes hydrogen and other fermentation byproducts generated by bacterial neighbors, affecting how efficiently the host harvests calories from food. It persists by producing surface molecules that mimic the host’s own gut lining and by competing effectively for nitrogen-containing nutrients.²²

Archaea as Ancestors of Eukaryotic Cells

Perhaps the most profound distinction between archaea and bacteria is their different relationships to eukaryotes. The leading model for the origin of complex cells holds that an archaeal host cell merged with a bacterial endosymbiont (which became the mitochondrion), producing the first eukaryote. The archaeal side of that partnership appears to come from a group called the Asgard archaea, discovered through deep-sea sediment DNA sequencing. Asgard genomes contain genes for cellular trafficking, a ubiquitin system, and cytoskeleton-like proteins that were previously considered exclusive to eukaryotes.²³

Recent phylogenetic analyses place the Asgard archaea and eukaryotes together on the tree of life, with growing evidence that many of the Asgard proteins function in ways that mirror their eukaryotic counterparts.²⁴ In other words, the complex cellular machinery you carry in your own cells did not appear from scratch. Much of it was already present in an archaeal ancestor. Bacteria contributed the mitochondrion, but the host cell’s internal architecture traces back to archaea. This makes the archaea-bacteria distinction not just a matter of biochemical curiosity but a key to understanding how complex life arose on Earth.

CRISPR and Immune Defense

CRISPR, the gene-editing tool now famous in biotechnology, was originally discovered as an immune defense system in prokaryotes. Both archaea and bacteria carry CRISPR-Cas systems, but the way these systems are distributed differs between the two domains. Bioinformatic analysis has shown that archaea tend to carry more CRISPR loci per genome and a greater variety of associated gene subtypes, all belonging to the more complex Class 1 systems. Bacteria carry fewer CRISPR loci on average and use a mix of Class 1 and Class 2 systems, with Class 1 accounting for roughly three-quarters of detected systems.²⁵

The Class 2 systems, which use a single large protein like Cas9 or Cas12 to do the cutting, are the ones that became famous as laboratory gene-editing tools. These appear to be absent from archaea. The reasons are not entirely clear, though archaeal viruses differ substantially from bacterial phages, which may have driven the two domains to evolve different defensive strategies over billions of years.

Archaea in the Ocean and Soil

For decades, archaea were thought of as niche organisms confined to boiling hot springs, salt flats, and oxygen-free swamps. That picture has been completely overturned. Single-celled planktonic archaea from a group once called Crenarchaeota (now largely reclassified as Thaumarchaeota) account for up to a third of all prokaryotic cells in the oceans by some estimates and are thought to drive most ammonia oxidation in both marine and soil environments.²⁶ The discovery that these archaea oxidize ammonia was itself a surprise, since for over a century ammonia oxidation had been attributed solely to bacteria.²⁷

This ecological footprint means archaea are not fringe organisms; they are major players in global nutrient cycling. Their ability to scavenge ammonia at vanishingly low concentrations gives them a decisive edge in nutrient-poor waters, while bacteria tend to dominate nutrient-rich settings. The practical consequence is that any model of the nitrogen cycle that ignores archaea is incomplete.

Industrial and Biotechnological Uses

The same biochemical oddities that set archaea apart from bacteria also make them attractive for biotechnology. Halophilic (salt-loving) archaea produce enzymes that stay active under high-salt and high-temperature conditions where bacterial enzymes fall apart, making them useful for industrial processes that involve dehydration or brines.²⁸ The purple membrane protein bacteriorhodopsin, produced by halophilic archaea, has been explored for use in photoelectric devices and artificial retinas. Some haloarchaea also produce biodegradable plastics (polyhydroxyalkanoates) and exopolysaccharides that could replace petroleum-based polymers, and their gas vesicles and surface-layer proteins have potential applications in drug delivery and nanotechnology.

Bacteria still dominate industrial microbiology, largely because they are easier to grow and genetically manipulate in the lab. But as tools for working with archaeal genetics improve, the unique properties of archaeal biomolecules are becoming more accessible. Their enzymes’ natural tolerance for extreme conditions often eliminates the need for the protein-engineering steps required to make bacterial enzymes work in harsh industrial settings.